Transcriptomics

Dataset Information

0

Hypomethylating agents induce epigenetic and transcriptional heterogeneity with implications for acute myeloid leukemia cell self-renewal

ABSTRACT: This SuperSeries is composed of the SubSeries listed below.

ORGANISM(S): Homo sapiens

PROVIDER: GSE256354 | GEO | 2025/07/21

REPOSITORIES: GEO

Json Xml

Similar Datasets

Genomics Hypomethylating agents induce epigenetic and transcriptional heterogeneity with implications for acute myeloid leukemia cell self-renewal
| PRJNA1079253 | ENA
Unknown Increased expression of CD70 in relapsed acute myeloid leukemia after hypomethylating agents.
| S-EPMC11564407 | biostudies-literature
Unknown Hypomethylating Agents and Immunotherapy: Therapeutic Synergism in Acute Myeloid Leukemia and Myelodysplastic Syndromes.
| S-EPMC7947882 | biostudies-literature
Unknown Hypomethylating Chemotherapeutic Agents as Therapy for Myelodysplastic Syndromes and Prevention of Acute Myeloid Leukemia.
| S-EPMC8308509 | biostudies-literature
Unknown Association of leukemia genetics with response to venetoclax and hypomethylating agents in relapsed/refractory acute myeloid leukemia.
| S-EPMC8855495 | biostudies-literature
Unknown Impact of splicing mutations in acute myeloid leukemia treated with hypomethylating agents combined with venetoclax.
| S-EPMC8095152 | biostudies-literature
Unknown Efficacy of the combination of venetoclax and hypomethylating agents in relapsed/refractory acute myeloid leukemia.
| S-EPMC6119155 | biostudies-literature
Unknown Impact of monocytic differentiation on acute myeloid leukemia patients treated with venetoclax and hypomethylating agents.
| S-EPMC11258555 | biostudies-literature
Unknown Prognostic risk signature in patients with acute myeloid leukemia treated with hypomethylating agents and venetoclax.
| S-EPMC10877112 | biostudies-literature
Unknown Cardiac events in patients with acute myeloid leukemia treated with venetoclax combined with hypomethylating agents.
| S-EPMC9631636 | biostudies-literature